logo
First “themed issue” of TRANSFUSION on thirty years of progress in blood safety since recognition of transfusion-associated AIDS
Closing the circle: a thirty-year retrospective on the AIDS/blood epidemic
Blood system changes since recognition of transfusion-associated AIDS
Transfusion-transmitted emerging infectious diseases: 30 years of challenges and progress
Comparison of human immunodeficiency virus assays in window phase and elite controller samples: viral load distribution and implications for transmission risk
Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios
Human immunodeficiency virus prevalence, incidence, and residual transmission risk in first-time and repeat blood donations in Zimbabwe: implications on blood safety
How safe is safe: new human immunodeficiency virus Type 1 variants missed by nucleic acid testing
An analysis of risk factors for human immunodeficiency virus infection among Chinese blood donors
Donors' perspectives on self-deferral of men having sex with men from blood donation
Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety?
Sensitivity of individual-donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis B virus infections
The diversity of chronic hepatitis B virus infections within blood donors in England and North Wales 2005 through 2010
Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription-mediated amplification assay
The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations
Interleukin-28B genetic variations and spontaneous clearance of hepatitis C antibody–positive blood donors in China
An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients
Head-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus Type 1 in blood donors
Comparative analysis of triplex nucleic acid test assays in United States blood donors
Routine screening of blood donations at Qingdao central blood bank, China, for hepatitis B virus (HBV) DNA with a real-time, multiplex nucleic acid test for HBV, hepatitis C virus, and human immunodeficiency virus Types 1 and 2
Degenerate polymerase chain reaction strategy with DNA microarray for detection of multiple and various subtypes of virus during blood screening
Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors
Viremic profiles in asymptomatic and symptomatic chikungunya fever: a blood transfusion threat?
Testing UK blood donors for exposure to human parvovirus 4 using a time-resolved fluorescence immunoassay to screen sera and Western blot to confirm reactive samples
Studies on the inactivation of human parvovirus 4
Human immunodeficiency virus transfusion transmission despite nucleic acid testing